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334Objective: Right thoracotomy using ventricular fibrillation with cooling has been used for redo mitral valve sur-
gery. This approach avoids the complications of redo sternotomy, such as injury to prior grafts and hemorrhage.
As a further refinement, we have used a beating heart technique to further minimize complications while
simplifying the operation.
Methods:We reviewed the outcomes of 450 patients who underwent redo mitral valve surgery via a right tho-
racotomy from 1996 to 2011 at the University of Michigan. Of these, 134 patients underwent redo mitral valve
surgery with ventricular fibrillation, and 316 patients underwent beating heart surgery. Although operative eras
were consecutive, patients’ age, risk factors, New York Heart Association, and preoperative left ventricular ejec-
tion fraction were not significantly different. Core temperature on cardiopulmonary bypass for beating heart sur-
gery was 32C versus 26C for ventricular fibrillation.
Results: Patients undergoing beating heart surgery had shorter periods of cardiopulmonary bypass: 81 9 min-
utes versus 113  36 minutes. Beating heart surgery required less blood products than ventricular fibrillation:
1.65  2 units versus 3.8  5 units packed red blood cells, 0.6  1.2 units versus 1.8  4 units fresh-frozen
plasma, and 1.02  4 versus 7.5  17 platelet packs (all P<.01). Conversely, patients receiving ventricular fi-
brillation required longer postoperative ventilation: 34 101 hours versus 15.5 27 hours (P<.01). The 30-day
mortality was similar for both (6.5% for beating heart and 7.4% for ventricular fibrillation), and postoperative
length of stay was the same at 7 days. Stroke rate was 2.6% for patients undergoing beating heart surgery and
3% for patients receiving ventricular fibrillation. Significant operative complications were uncommon; there
was no catastrophic hemorrhage, and only 2 patients receiving ventricular fibrillation and 2 patients undergoing
beating heart surgery required reexploration.
Conclusions: As reoperative cardiac surgery continues to increase, techniques that safely facilitate operation
while improving outcome should be adopted. As an operative alternative, redo right thoracotomy mitral valve
surgery on the beating heart is associated with shorter bypass time, less transfusion requirements, shorter
postoperative ventilation, and lower mortality. This safe and effective approach should be considered for this
complex operation. (J Thorac Cardiovasc Surg 2012;144:334-9)As the population ages, the incidence of reoperative cardiac
surgery is projected to continue to increase.Reoperativevalve
surgery is known to bemore complex and associated with in-
creased morbidity and mortality.1,2 The right thoracotomy
approach with fibrillatory arrest for redo cardiac surgery,
especially for atrioventricular valve surgery, is a standard
and known alternative to repeat median sternotomy. It
avoids complications of repeat sternotomy, including
catastrophic reentry into the heart, injury to previous bypass
grafts, and significant hemorrhage.3-5 Furthermore, right
thoracotomy provides excellent exposure to the mitral valvee Section of Cardiac Surgery, University of Michigan, Ann Arbor, Mich.
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The Journal of Thoracic and Cardiovascular Surgwhile avoiding extensive mediastinal dissection. Right
thoracotomy may also decrease cardiopulmonary bypass
(CPB) time, allow for reduced transfusion requirements,
and decrease the need for reoperation for bleeding.6-9
With this approach, myocardial protection commonly is
accomplished with moderate hypothermic fibrillatory arrest
(ventricular fibrillation [VF]). We have previously shown,
as have others, that this method is often superior to repeat
median sternotomy with aortic crossclamping.9-11 To
further refine the right thoracotomy redo technique, we
have used a beating heart (BH) method. We report
a retrospective analysis of a single institutional experience
of the BH method for redo mitral valve surgery via a right
thoracotomy, highlighting and comparing it with our
ventricular fibrillatory arrest experience and data from the
Society of Thoracic Surgeons (STS) for redo mitral valve
repair in patients with previous sternotomy.PATIENTS AND METHODS
From June 1996 to March 2011, 450 patients underwent reoperative
mitral valve surgery via right thoracotomy at the University of Michiganery c August 2012
Abbreviations and Acronyms
BH ¼ beating heart
CPB ¼ cardiopulmonary bypass
ICU ¼ intensive care unit
STS ¼ Society of Thoracic Surgeons
VF ¼ ventricular fibrillation
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went redo mitral valve surgery via a right thoracotomy with hypothermic
ventricular fibrillatory arrest. More recently, from 1999 to 2011, 316 pa-
tients underwent mitral valve surgery on the BH via a right thoracotomy.
The preoperative patient demographics for both groups are shown in
Table 1. In the VF group, the mean age was 63 years, 57% were male,
and the mean New York Heart Association class was 2.7  0.8. In the
BH group, the mean age was 63 years, 58% were male, and the New
York Heart Association class was 2.6  0.7. The mean ejection fraction
was 36  18 for the VF group and 38  9 for the BH group. Previous op-
erations via a sternotomy included coronary artery bypass graft, mitral
valve repair, mitral valve replacement, aortic valve replacement, tricuspid
valve repair, ventricular septal defect repair, automatic implantable cardiac
defibrillator, and atrioventricular canal. Both patient groups had undergone
1 to 4 previous cardiac procedures with a mean of 1.2  0.6 procedures in
the VF group and 1.4  0.3 procedures in the BH group. The mean time
from the last operative procedure to the current procedure was 7  6 years
for the VF group and 6 7 years for the BH groups. The indication for op-
eration was symptomatic congestive heart failure as described by the
American College of Cardiology/American Heart Association guidelines.
Preoperatively, all patients were receiving maximal medical therapy for
congestive heart failure, including digoxin, diuretics, angiotensin-
converting enzyme inhibitors, aldactone, and beta-blockers as tolerated.
All patients had double-lumen endotracheal tubes placed to allow for
left lung ventilation while the right lung was decompressed. The patient
was positioned in the full right lateral thoracotomy position (left side
down), and the groin was prepped and draped to allow for potential femoral
arterial cannulation. An external defibrillator was placed before draping for
subsequent defibrillation. Preoperative and intraoperative color flow
2-dimensional Doppler transesophageal echocardiography were performed
in all patients. Standard intraoperative cardiac monitoring, including arte-
rial and central venous pressure monitoring, and thermodilution pulmonary
artery catheterization were used. The chest was entered by a limited lateral
thoracotomy incision via the fifth interspace. The pericardium was entered
anterior to the phrenic nerve. Arterial cannulation was primarily estab-
lished via the lateral ascending aorta. When this was not feasible, the right
common femoral artery was used for arterial access. Direct bicaval venous
cannulation with vacuum assist was used in all patients. Patients receiving
fibrillatory arrest were cooled to 26C, and fibrillation was induced in 3 pa-
tients in whom it was not spontaneously achieved. Patients in the BH group
were allowed to drift to 32C. All patients were placed in the Trendelen-
burg position and rotated to elevate the left atrium relative to the left ven-
tricle. The aorta was vented with an air needle on suction inserted into the
ascending aorta, proximal to the arterial cannula. The interatrial groove
was generously dissected to expose the left atrium. Mitral valve repair or
replacement was performed as determined by the patient’s indication or
surgeon’s preference and was accomplished via a direct left atriotomy. Ex-
posure was facilitated with the use of a self-retaining retractor system
(Thompson, Traverse City, Mich). A vent was routinely placed in the right
superior pulmonary vein, through a separate stab incision, and passed
across into the left inferior pulmonary vein. At the conclusion of the mitral
valve repair or bioprosthetic valve replacement, the left ventricular vent
was placed across the valve; for mechanical valve replacements, an 8FThe Journal of Thoracic and CaFoley catheter was positioned across the valve to prevent air entrapment
while the atrium was still open. CO2 insufflation was not used. Transeso-
phageal echocardiography was used to confirm air removal. Two chest
tubes were routinely placed, 1 anterior and 1 posterior. The thoracotomy
incision was closed in the standard fashion. When the procedure was com-
plete, the patient was returned to the supine position and the dual lumen en-
dotracheal tube was replaced with a single lumen tube for postoperative
ventilation.
End point measures included operative time, CPB time, transfusion re-
quirements, duration of postoperative ventilation, intensive care unit (ICU)
stay, postoperative hospital stay, stroke, and hospital mortality. Stroke, as
defined by the STS database, is a central neurologic deficit persisting
more than 72 hours after surgery. Hospital mortality is defined as in-
hospital death and 30-day postoperative mortality. Statistical analysis
was performedwith Statistical Package for the Social Sciences v16 desktop
software (SPSS Inc, Chicago, Ill). Continuous data were compared using
Student t test or Wilcoxon rank-sum test. All tests were 2 sided.RESULTS
Of the 134 patients undergoing redo right thoracotomy
with fibrillatory arrest, mitral valve replacement was per-
formed in 55 (41%) and repair was accomplished in the re-
maining 79. Mitral valve replacement was performed in 101
patients of the BH group (33%), and mitral valve repair was
performed in 215 patients in the BH group. The decision to
replace or repair the valve was made at the time of surgery
and dependent on the disease process and operative findings
of the native valve or a previously replaced valve. Concom-
itant operative procedures included patent foramen ovale
closure in 20 patients in the VF group and 43 patients in
the BH group, and tricuspid valve repair in 13 patients in
theVF group and 72 patients in the BH group, through a sep-
arate right atriotomy. The decision to use femoral cannula-
tion rather than direct aortic cannulation was due to
a previously placed ascending aortic graft, location of prox-
imal vein grafts, or calcification of the aortic wall. Femoral
cannulation was used in 19 patients in the VF group (14%)
and 28 patients in the BH group (9%).
Patients in the BH group were in the operating room for
a mean time of 187 62 minutes, and the patients in the VF
group averaged 229 52 minutes (P<.01). The CPB times
were also shorter for the BH group. The BH group averaged
82  6 minutes of CPB, compared with 113  36 minutes
for the VF group (P<.01). Time to extubation was shorter
for the BH group. The length of postoperative mechanical
ventilation in the BH group was 11  17 hours compared
with 34  101 hours in the VF group (P<.01). The BH
group also had less transfusion requirements of blood, clot-
ting factors, and platelets. The mean ICU stay was 2.1 2.0
days for the BH group and 2.4  2.1 days for the VF group
(P¼ .45). There was no difference in postoperative hospital
stay of 7.1  6.9 days for the BH group and 7.3  5.8 days
for the VF group. The operative and postoperative charac-
teristics are summarized in Table 2.
Overall postoperative complications were low for both
groups. Two patients from each group had significantrdiovascular Surgery c Volume 144, Number 2 335
TABLE 1. Preoperative characteristics
Fibrillatory arrest
(134)
Beating heart
(316)
Age, y 63  13 63  15
Gender
Male 77 174
Female 57 143
Mean NYHA functional class 2.7  0.8 2.6  0.7
Mean ejection fraction (%) 36  13 38  9
Previous surgery
CABG 97 239
Mitral valve repair 16 69
Mitral valve replacement 10 41
Ascending aortic replacement 1 15
Aortic valve replacement 16 48
PFO closure 4 6
Tricuspid valve annuloplasty 5 18
VSD repair 2 1
AV canal repair 1 0
ICD via sternotomy 3 0
No. of previous cardiac operations 1.2  0.6 1.4  0.3
Time from previous operation (y) 7  6 6  7
NYHA, New York Heart Association; CABG, coronary artery bypass grafting; PFO,
patent foramen ovale; VSD, ventricular septal defect; AV, atrioventricular; ICD, im-
plantable cardioverter-defibrillator.
TABLE 3. Morbidity and mortality characteristics
Fibrillatory arrest Beating heart
Stroke 4 7
Death 10 22
Pleural effusion 5 8
Hemothorax 2 2
Pneumothorax 3 6
Renal failure requiring HD 2 4
Sepsis 4 3
Pneumonia 2 3
Urinary tract infection 4 6
HD, Hemodialysis.
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curred in 8 patients (2.6%) in the BH group and 4 patients
(3%) in the VF group. Other complications included pleural
effusions, hemothorax, pneumothorax, renal failure requir-
ing dialysis, sepsis, pneumonia, and urinary tract infection,
none of which differed between groups (Table 3). There was
1 intraoperative death in the BH group from an atrioventric-
ular groove dehiscence. There was no difference in 30-day
mortality between groups. There were 22 deaths (6.9%) in
the BH group versus 10 patients (7.4%) in the VF group
(P ¼ .34). In the VF group, cause of death was related to
multisystem organ failure in 4 patients, sepsis in 3 patients,
cerebrovascular accident in 2 patients, and complications of
ischemic colitis in 1 patient. In the BH group, the cause of
death was cerebrovascular accident in 5 patients,TABLE 2. Operative and postoperative characteristics
Ventricular
fibrillation Beating heart
P
value
Temperature 26.2  2.2 32.6  1.7 <.01
Operative time 229  52 187  62 <.01
CPB time (min) 113  36 84  18 <.01
PRBC (U) 3.8  5 2.8  3 <.01
FFP (U) 1.8  4 0.7  1.3 <.01
Platelets (packs) 1.5  3 0.5  0.8 <.01
Time to extubation (h) 34  101 15  27 <.01
Femoral cannulation 19 28 NS
Postoperative ICU stay (d) 2.4  2.1 2.1  2.0 NS
Postoperative stay (d) 7.3  5.8 7.1  6.9 NS
CPB, Cardiopulmonary bypass; PRBC, packed red blood cell; FFP, fresh-frozen
plasma; ICU, intensive care unit; NS, not significant.
336 The Journal of Thoracic and Cardiovascular Surgmultisystem organ failure in 13 patients, and sepsis from
pneumonia in 4 patients.
DISCUSSION
Right thoracotomy for operation on the mitral valve is not
new. It was one of the early approaches to the mitral valve
and has been used for more than 60 years. Several previous
series have documented its utility and highlighted the ad-
vantages in reoperative mitral valve procedures.8-13 This
single institution series presented further validates and
supplements these published reports and results with
a BH operative technique. It is known that redo
sternotomy usually requires dissection of the aorta and
right side of the heart for cannulation and access to the
mitral valve, and frequently dissection of the left side to
permit the heart to rotate in the pericardium to improve
visualization of the mitral valve when opening the left
atrium. Such extensive dissection increases the risk of
bleeding and injury to venous and arterial bypass grafts.
A right thoracotomy facilitates efficient exposure to the
mitral valve while avoiding extensive mediastinal
dissection, bypass grafts, and the anterior heart, which are
not in the operative field.
VF with moderate to deep hypothermia traditionally pro-
vided for myocardial protection and was used with a right
thoracotomy. Early in our experience, we used a similar
technique. To further simplify intervention on this complex
patient population, we adopted a warmer BH approach,
minimizing hypothermia and avoiding fibrillatory arrest.
This BH approach obviates the need for deeper hypother-
mia because of subendocardial hypoperfusion mismatches,
which are commonly seen with VF. During electrically in-
duced fibrillation, oxygen delivery to the left ventricle is
markedly reduced and coronary flow is redistributed away
from the subendocardium.14 By keeping the heart in its nat-
ural beating state with antegrade coronary flow, the risk of
reperfusion injury is potentially mitigated.
Also during ischemic arrest, myocardial edema increases
in the static diastolic state and may cause cardiac dysfunc-
tion. By keeping the heart beating, myocardial edema is de-
creased and function may be maintained, which may be ofery c August 2012
FIGURE 1. Intraoperative view of BH redo mitral valve surgery: Photo-
graph (A) and sketch (B) of a third-time redo with intact thoracic and sa-
phenous grafts. LV, Left ventricle.
Romano et al Acquired Cardiovascular Disease
A
C
Dparticular importance in these patients with already im-
paired ventricular function.14 In this series of patients un-
dergoing BH surgery, myocardial protection was excellent
and failure to wean from CPB was not noted. Others have
also suggested that warm BH surgery may also provide en-
hanced myocardial protection and decrease reperfusion
insult.
Previous reports have cited less transfusion requirements
for reoperative mitral valve surgery via the right chest com-
pared with median sternotomy.14,15 In our series, patients in
the BH group were not actively cooled but were allowed to
drift to approximately 32C, and the heart was left beating.
These patients were noted to have significantly lower
transfusion requirements, almost routinely requiring half
the amount of blood products. We acknowledge that, over
time, emerging technologies and techniques certainly
could have played a role in decreased coagulopathy.
Nonetheless, it would appear that the warmer core
temperatures decrease hypothermic-mediated coagulopathy.
Engelman and colleagues16 showed fibrinolysis was sig-
nificantly decreased in patients undergoing cardiac surgery
if CPB was maintained at 32C. The decrease in the forma-
tion of plasmin was significantly different than emergence
from cold CPB. The warmer core temperature can be ex-
trapolated to shorter CPB duration. In our series, CPB
was significantly shorter for BH than VF. A BH technique
eliminates the additional time required for cooling and re-
warming for VF. The added benefit of shorter periods of
CPB may also be responsible for less transfusion require-
ments. Although the use of aprotinin in patients undergoing
redo operations during some of this era may have played
a role in the overall lower incidence of bleeding, it was bal-
anced between groups and not used in the later years of BH
surgery, when in fact no rebound increase in bleeding rate
has been noted. Finally, the decision to replace or repair
the mitral valve was dependent on the operative findings
or a previously replaced valve. There was a higher mitral
valve repair rate in the BH series than in VF, which may
have influenced CPB time and therefore complications.
We also noted shorter time periods of mechanical venti-
lation in the BH postoperative period. It has been suggested
that a right thoracotomy may compromise pulmonary func-
tion especially when compared with repeat median sternot-
omy.8 Pleuro-pulmonary complications were not significant
in our series. Our overall time of postoperative ventilation
was not excessively long. Perhaps the lower transfusion re-
quirements indicate less hemodynamic instability, favoring
extubation criterion. We have well-established postopera-
tive mechanical ventilation and pulmonary protocols that
have evolved over time. Postoperative mechanical ventila-
tion time of 34 hours for VF and 15 hours for BH in our se-
ries compares favorably to the STS national database mean
of 58 hours of postoperative ventilation for reoperative mi-
tral valve surgery.17The Journal of Thoracic and CaWe were able to establish central cannulation for CPB
almost routinely. It has been suggested that a right thoracot-
omy necessitates peripheral cannulation and may be associ-
ated with increased cerebral vascular accidents.18 The
lateral ascending aorta and superior and inferior venae
cavae are readily accessible. The factors that tended to
lead to femoral cannulation were previously placed pros-
thetic ascending aortic grafts, aberrant proximal venous by-
pass graft location, or calcified aortic wall. Femoral
cannulation was required in only 10.4% (47) of the total se-
ries of 450 patients, and there was no difference between the
VF and BH groups, with less in the later part of the series.
It is well known that the right thoracotomy offers excel-
lent exposure to the mitral valve. The surgeon is afforded
the luxury of looking directly down on the valve through
the left atriotomy. Also, the BH approach enables the as-
sessment of the function and geometry of the valve
(Figure 1) and subsequently accurately facilitates repair
throughout the operation, which is not possible during static
fibrillation.19rdiovascular Surgery c Volume 144, Number 2 337
TABLE 4. Comparison with Society of Thoracic Surgeons’ National
Database for reoperative isolated mitral valve surgery
Fibrillatory
arrest
Beating
heart
STS National
Database
Age 63 65 63
Mean ejection fraction 36 38 49
Postoperative ICU stay (d) 2.4 2.1 4.9
Postoperative stay (d) 7.3 7.1 11.1
Time to extubation (h) 34 11 58
CPB time (min) 113 82 134
Reoperation for bleeding (%) 1.5 0.6 5
Stroke (%) 3 2.6 3
Mortality (%) 7.4 6.9 8.2
STS, Society of Thoracic Surgeons.
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meticulous technique to ensure complete removal of intra-
cardiac air. We routinely use transesophageal echocardiog-
raphy to assess the competence of the mitral and aortic
valves and to evaluate air removal. In addition, the patient
is placed in the Trendelenburg position before opening the
heart, an air evacuation needle is placed in the ascending
aorta, and the air in the left ventricle is evacuated by making
the mitral valve incompetent with a vent, thereby preventing
the unloaded left ventricle from ejecting air. A recent series
from the Cleveland Clinic surmised that the right thoracot-
omy increased the risk of mitral valve reoperation and was
associatedwith an increase in stroke. However, in that report
by Svensson and colleagues,18 of 80 patients undergoing
right thoracotomy redo mitral valve surgery (of 2469 redo
surgeries), crossclamping of the aorta was frequently used,
as was hypothermic circulatory arrest, and femoral cannula-
tion was used almost exclusively. Their overall mortality
was 6.3%, similar to this series of 450 patients, but their
stroke rate was high at 7.5%, versus 2.6% in this BH series.
We agree with their findings that right thoracotomy with VF
and femoral cannulation may be suboptimal. Direct aortic
cannulation and a warm BH technique are associated with
a lower incidence of stroke. To further compare our findings,
we used the STS national database as a reference for re-
operative isolated mitral valve surgery (Table 4). The BH
group presented had shorter CPB time, mechanical ventila-
tion time, and postoperative ICU and hospital stay. Further-
more, although statistical analysis is not possible, mortality
and stroke seem favorable with a BH approach.
Finally, there are several considerations that may pre-
clude redo right thoracotomy for mitral valve repair, and
these also pertain to the warm BH method. Briefly, simulta-
neous coronary artery bypass grafting will require exposure
that may be accomplished only with median sternotomy.
Significant aortic insufficiency would be a contraindication,
and aortic valve replacement would be indicated. Consider-
ation should be given to patients with significant pulmonary
pathology or respiratory insufficiency.338 The Journal of Thoracic and Cardiovascular SurgCONCLUSIONS
We acknowledge the limitations of this retrospective, ob-
servational operative technique study and conclusions that
may be drawn. Furthermore, well-established inherent pa-
tient factors certainly determine long-term outcome. None-
theless, the data presented show that in appropriately
selected patients, reoperativemitral valve surgery via a right
thoracotomy on the BH is a safe, effective, and reliable pro-
cedure that simplifies the operative approach. Difficult me-
diastinal dissection is avoided, and excellent exposure and
evaluation of the abnormal valve pathology and subsequent
repair or replacement of the mitral valve are afforded to the
operating surgeon. The associated shorter bypass and oper-
ative times, lower transfusion requirements, and shorter
postoperative mechanical ventilation time, with acceptable
low morbidity and mortality, compare favorably to national
averages for reoperative mitral valve surgery. BH surgery
via right thoracotomy for reoperative mitral valve surgery
is a safe and effective alternative for cardiac surgeons to
consider for their patients.References
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